Table 3.
Term a ID | Term Description | Gene Symbols | p-Value | FDR b |
---|---|---|---|---|
GO terms for co-expressed mRNAs of TCONS_00013557 | ||||
GO:0001502 | cartilage condensation | ACAN; COL11A1; COL2A1 | 1.62 × 10−6 | 0.000197 |
GO:0030199 | collagen fibril organization | ACAN; COL11A1; COL2A1 | 1.90 × 10−5 | 0.001158 |
GO:0006029 | proteoglycan metabolic process | COL11A1; COL2A1 | 3.35 × 10−5 | 0.001362 |
GO:0002062 | chondrocyte differentiation | MATN1; COL2A1; OSR2 | 7.32 × 10−5 | 0.002015 |
GO:0060272 | embryonic skeletal joint morphogenesis | OSR2; COL2A1 | 8.26 × 10−5 | 0.002015 |
GO:0030198 | extracellular matrix organization | COL9A1; COL11A1; IBSP; COL2A1 | 0.0002075 | 0.004219 |
GO:0002063 | chondrocyte development | ACAN; COL11A1 | 0.0003181 | 0.005543 |
GO:0035987 | endodermal cell differentiation | COL11A1; COL12A1 | 0.0011231 | 0.017127 |
GO:0030574 | collagen catabolic process | COL11A1; COL2A1 | 0.0023463 | 0.031805 |
GO:0048704 | embryonic skeletal system morphogenesis | COL11A1; OSR2 | 0.0026094 | 0.031835 |
GO:0005578 | proteinaceous extracellular matrix | MATN1; COL12A1; COL9A2; LECT1; ACAN; COL9A1; CHAD | 3.53 × 10−8 | 1.06 × 10−6 |
GO:0005594 | collagen type IX trimer | COL9A1; COL9A2 | 1.49 × 10−5 | 0.000224 |
GO:0005788 | endoplasmic reticulum lumen | COL9A1; COL11A1; COL2A1 | 0.0010591 | 0.010591 |
GO:0031012 | extracellular matrix | COL12A1; IBSP; COL2A1 | 0.0015573 | 0.01168 |
GO:0005859 | muscle myosin complex | LOC103348296 | 0.0044683 | 0.02681 |
GO:0005604 | basement membrane | ACAN; COL2A1 | 0.0068787 | 0.034393 |
GO:0001739 | sex chromatin | SUZ12 | 0.0096571 | 0.039576 |
GO:0005576 | extracellular region | PRSS35; COL11A1; COL9A1; IBSP; COL2A1 | 0.0106248 | 0.039576 |
GO:0016461 | unconventional myosin complex | LOC103348296 | 0.0118729 | 0.039576 |
GO:0030020 | extracellular matrix structural constituent conferring tensile strength | COL9A1; COL2A1 | 1.45 × 10−5 | 0.000439 |
GO:0005201 | extracellular matrix structural constituent | MATN1; COL11A1; ACAN | 2.37 × 10−5 | 0.000439 |
GO:0030674 | protein binding, bridging | CRADD; COL11A1 | 0.0015134 | 0.018665 |
GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity | PEMT | 0.0035077 | 0.021631 |
GO:0080101 | phosphatidyl-N-dimethylethanolamine N-methyltransferase activity | PEMT | 0.0035077 | 0.021631 |
GO:0004608 | phosphatidylethanolamine N-methyltransferase activity | PEMT | 0.0035077 | 0.021631 |
GO:0033699 | DNA 5′-adenosine monophosphate hydrolase activity | APTX | 0.0052572 | 0.023118 |
GO:0048407 | platelet-derived growth factor binding | COL2A1 | 0.0070038 | 0.023118 |
GO:0016918 | retinal binding | CRABP1 | 0.0070038 | 0.023118 |
GO:0008429 | phosphatidylethanolamine binding | PEMT | 0.0070038 | 0.023118 |
GO terms for co-expressed mRNAs of XR_518424.2 | ||||
GO:0007519 | skeletal muscle tissue development | VGLL2; CAV1; HOXD10; CAV1 | 5.64 × 10−6 | 0.000954 |
GO:0006641 | triglyceride metabolic process | CAV1; PTPN11; CAV1 | 1.78 × 10−5 | 0.000954 |
GO:1901979 | regulation of inward rectifier potassium channel activity | CAV1; CAV1 | 2.25 × 10−5 | 0.000954 |
GO:0003057 | regulation of the force of heart contraction by chemical signal | CAV1; CAV1 | 2.25 × 10−5 | 0.000954 |
GO:0086098 | angiotensin-activated signaling pathway involved in heart process | CAV1; CAV1 | 2.25 × 10−5 | 0.000954 |
GO:0033484 | nitric oxide homeostasis | CAV1; CAV1 | 2.25 × 10−5 | 0.000954 |
GO:0001937 | negative regulation of endothelial cell proliferation | CAV1; LOC100339409; CAV1 | 2.69 × 10−5 | 0.000954 |
GO:0070836 | caveola assembly | CAV1; CAV1 | 3.00 × 10−5 | 0.000954 |
GO:0060056 | mammary gland involution | CAV1; CAV1 | 3.00 × 10−5 | 0.000954 |
GO:0019065 | receptor-mediated endocytosis of virus by host cell | CAV1; CAV1 | 3.86 × 10−5 | 0.000954 |
GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex | CAV1; CAV1 | 9.36 × 10−5 | 0.004681 |
GO:0002080 | acrosomal membrane | CAV1; CAV1 | 0.001231186 | 0.03078 |
GO:0030018 | Z disc | FHL3; FHOD3; RA_M006_JSM7BED4F | 0.002062968 | 0.034383 |
GO:0016504 | peptidase activator activity | CAV1; CAV1 | 0.000356053 | 0.023856 |
GO:0071209 | U7 snRNA binding | LSM10 | 0.006180344 | 0.045963 |
GO:0034988 | Fc-gamma receptor I complex binding | RA_M006_JSM7BED4F | 0.006180344 | 0.045963 |
GO:0015036 | disulfide oxidoreductase activity | TXNL1 | 0.006180344 | 0.045963 |
GO:0043532 | angiostatin binding | LOC100339409 | 0.006180344 | 0.045963 |
GO:0005519 | cytoskeletal regulatory protein binding | CDC42EP3 | 0.007206806 | 0.045963 |
GO:0042030 | ATPase inhibitor activity | LOC100339409 | 0.007206806 | 0.045963 |
GO:0004871 | signal transducer activity | TRIM13; RA_M006_JSM7BED4F; TMEM9B | 0.007345729 | 0.045963 |
GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding | BCL6 | 0.008232242 | 0.045963 |
GO:0052731 | phosphocholine phosphatase activity | PHOSPHO1 | 0.008232242 | 0.045963 |
a Term: GO term or pathway term; b FDR: false discovery rate.